Denmark · Delayed Price · Currency is DKK Embla Medical Statistics
Total Valuation
Embla Medical has a market cap or net worth of DKK 12.73 billion. The enterprise value is 15.56 billion.
| Market Cap | 12.73B |
| Enterprise Value | 15.56B |
Important Dates
The last earnings date was Tuesday, February 3, 2026.
| Earnings Date | Feb 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Embla Medical has 427.15 million shares outstanding. The number of shares has increased by 0.88% in one year.
| Current Share Class | 427.15M |
| Shares Outstanding | 427.15M |
| Shares Change (YoY) | +0.88% |
| Shares Change (QoQ) | -2.39% |
| Owned by Insiders (%) | 0.08% |
| Owned by Institutions (%) | 71.95% |
| Float | 161.36M |
Valuation Ratios
The trailing PE ratio is 24.00 and the forward PE ratio is 19.72. Embla Medical's PEG ratio is 1.10.
| PE Ratio | 24.00 |
| Forward PE | 19.72 |
| PS Ratio | 2.15 |
| PB Ratio | 2.23 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.10 |
| P/OCF Ratio | 15.09 |
| PEG Ratio | 1.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.14, with an EV/FCF ratio of 22.12.
| EV / Earnings | 29.34 |
| EV / Sales | 2.63 |
| EV / EBITDA | 13.14 |
| EV / EBIT | 18.62 |
| EV / FCF | 22.12 |
Financial Position
The company has a current ratio of 1.48, with a Debt / Equity ratio of 0.60.
| Current Ratio | 1.48 |
| Quick Ratio | 0.83 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 4.90 |
| Interest Coverage | 6.39 |
Financial Efficiency
Return on equity (ROE) is 9.98% and return on invested capital (ROIC) is 7.25%.
| Return on Equity (ROE) | 9.98% |
| Return on Assets (ROA) | 4.77% |
| Return on Invested Capital (ROIC) | 7.25% |
| Return on Capital Employed (ROCE) | 8.78% |
| Weighted Average Cost of Capital (WACC) | 5.92% |
| Revenue Per Employee | 1.48M |
| Profits Per Employee | 132,523 |
| Employee Count | 4,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 2.27 |
Taxes
In the past 12 months, Embla Medical has paid 154.51 million in taxes.
| Income Tax | 154.51M |
| Effective Tax Rate | 22.51% |
Stock Price Statistics
The stock price has decreased by -12.87% in the last 52 weeks. The beta is 0.46, so Embla Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -12.87% |
| 50-Day Moving Average | 33.36 |
| 200-Day Moving Average | 32.36 |
| Relative Strength Index (RSI) | 27.53 |
| Average Volume (20 Days) | 56,849 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Embla Medical had revenue of DKK 5.91 billion and earned 530.09 million in profits. Earnings per share was 1.24.
| Revenue | 5.91B |
| Gross Profit | 3.68B |
| Operating Income | 793.17M |
| Pretax Income | 686.57M |
| Net Income | 530.09M |
| EBITDA | 955.05M |
| EBIT | 793.17M |
| Earnings Per Share (EPS) | 1.24 |
Balance Sheet
The company has 652.03 million in cash and 3.44 billion in debt, with a net cash position of -2.79 billion or -6.54 per share.
| Cash & Cash Equivalents | 652.03M |
| Total Debt | 3.44B |
| Net Cash | -2.79B |
| Net Cash Per Share | -6.54 |
| Equity (Book Value) | 5.70B |
| Book Value Per Share | 13.24 |
| Working Capital | 944.13M |
Cash Flow
In the last 12 months, operating cash flow was 843.57 million and capital expenditures -140.40 million, giving a free cash flow of 703.17 million.
| Operating Cash Flow | 843.57M |
| Capital Expenditures | -140.40M |
| Free Cash Flow | 703.17M |
| FCF Per Share | 1.65 |
Margins
Gross margin is 62.30%, with operating and profit margins of 13.43% and 8.97%.
| Gross Margin | 62.30% |
| Operating Margin | 13.43% |
| Pretax Margin | 11.62% |
| Profit Margin | 8.97% |
| EBITDA Margin | 16.17% |
| EBIT Margin | 13.43% |
| FCF Margin | 11.90% |
Dividends & Yields
Embla Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.88% |
| Shareholder Yield | -0.88% |
| Earnings Yield | 4.16% |
| FCF Yield | 5.52% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Embla Medical has an Altman Z-Score of 3.06 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.06 |
| Piotroski F-Score | 5 |